Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The leadership of the Senate Committee on Health, Education, Labor and Pensions (HELP) listed some key retirement and health priorities for the Committee for this session of Congress, during a hearing ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

Employers who sponsor health plans typically utilize administrators, like pharmacy benefits managers, to facilitate those ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

At today's confirmation hearing, Democratic senators were skeptical of the HHS Secretary nominee Robert F. Kennedy Jr.'s ...